A PROSPECTIVE, OPEN-LABEL, NON-COMPARATIVE STUDY OF PALIVIZUMAB PROPHYLAXIS IN CHILDREN AT HIGH RISK OF SERIOUS RESPIRATORY SYNCYTIAL VIRUS DISEASE IN THE RUSSIAN FEDERATION ArticleTurti T.V., Baibarina E.N., Degtiareva E.A., Keshishyan E.S., Lobzin Y.V., Namazova-Baranova L.S., Prodeus A.P., Gudkov K.M., Kruglova A.I., Schulz G.A., Notario G.F.BMC Research Notes. Том 5. 2012.
FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION ArticleБаранов А.А., Baranov A.A., Намазова-Баранова Л.С., Namazova-Baranova L.S., Куличенко Т.В., Kulichenko T.V., Бакрадзе М.Д., Bakradze M.D., Дегтярева Е.А., Degtiareva E.A., Огородова Л.М., Ogorodova L.M., Гудков К.М., Gudkov K.M., Таточенко В.К., Tatochenko V.K., Gooch K.L., Notario G., Khong H., Buesch K.Педиатрическая фармакология. Том 8. 2011. С. 61-66
